Express Pharma - Page 569 of 2180 - Express Pharma

Mumbai Experience Center reflects Agilent’s continued commitment to India

Lupin completes acquisition of VISUfarma

Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US

Mix-and-match trial finds additional dose of COVID-19 vaccine safe and immunogenic

Israel broadens eligibility for fourth shot of COVID vaccine

Lonza’s full-year core EBITDA up 20.7 per cent on vaccine demand

Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market approval

Sun Pharma launches Cequa, maiden dry eye treatment with nanomicellar technology in Canada

JB Chemicals and Pharmaceuticals to acquire brands from Sanzyme

Torrent Pharma December quarter profit slips 16 per cent to Rs 249 crores

‘Nocebo effect’ behind two-thirds of COVID vax side effects: Study

US limits use of Regeneron and Eli Lilly COVID-19 antibody treatments amid Omicron spread

Omicron may not evade all monoclonal antibodies, lab study suggests